PCV104 - Is Edoxaban Cost-Effective For Non-Valvular Atrial Fibrillation Patients Treated With Vitamin K Antagonists In Spain?
| Autor: | Lekuona, I, Anguita, M, Zamorano, JL, Barja, P, Rodríguez, JM, Pérez-Alcántara, F |
|---|---|
| Zdroj: | In Value in Health November 2015 18(7):A392-A392 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect